Hélène GoussaultSébastien GendarmeJean-Baptiste AssiéCamille JungSalomé EpaudChristelle AlgansNoémie Salaun-PenquerMathilde RousseauAndrea LazattiChristos Chouaïd

*Author details available on the publication

PMID: 35567378 / DOI: 10.1002/cam4.4821

Published: 14 May 2021

Despite therapeutic advances, lung cancer remains the first cause of death from cancer. The main objective of this study was to identify risk factors associated with death within 3- months of the first hospitalization for lung cancer in France

Almost 1 in 5 patients diagnosed with lung cancer in France died within 3 months post- diagnosis. Improving survival requires diagnosis at an ear-lier stage and better organization of diagnosis and specific care pathways.

Discover our use-case

Other resources you may be interested in

A Prospective Pharmacoepidemiologic Cohort Study in 30 French NICUs From 2014 to 2020

A Prospective Pharmacoepidemiologic Cohort Study in 30 French NICUs From 2014 to 2020

No consensus exists about the doses of analgesics, sedatives, anesthetics, and paralytics used in critically ill neonates.

Comparison of explanatory methods: influence of characteristics

Comparison of explanatory methods: influence of characteristics

Kaduceo, co-author of work presented at the 24th International Workshop on Design, Optimization, Languages and Analytical Processing of Big Data